BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38049563)

  • 1. Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
    Karamali N; Mahmoudi Z; Roghani SA; Assar S; Pournazari M; Soufivand P; Karaji AG; Rezaiemanesh A
    Clin Rheumatol; 2024 Jan; 43(1):147-157. PubMed ID: 38049563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of DMARDs and methylprednisolone treatment on the gene expression levels of HSPA5, MMD, and non-coding RNAs MALAT1, H19, miR-199a-5p, and miR-1-3p, in patients with rheumatoid arthritis.
    Mahmoudi Z; Karamali N; Roghani SA; Assar S; Pournazari M; Soufivand P; Salari F; Rezaiemanesh A
    Int Immunopharmacol; 2022 Jul; 108():108878. PubMed ID: 35623291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA NEAT1 and its targets (microRNA-21 and microRNA-125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome.
    Yang J; Wang S; Liu L; Wang J; Shao Y
    J Clin Lab Anal; 2021 Dec; 35(12):e24076. PubMed ID: 34708894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris.
    Safari F; Damavandi E; Rostamian AR; Movassaghi S; Imani-Saber Z; Saffari M; Kabuli M; Ghadami M
    Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):326-337. PubMed ID: 34134454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients.
    Rezaeepoor M; Pourjafar M; Tahamoli-Roudsari A; Basiri Z; Hajilooi M; Solgi G
    Int Immunopharmacol; 2020 Jun; 83():106404. PubMed ID: 32197230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-α inhibitors: a machine learning approach.
    Kim W; Yeon HR; Kim JH; Kim JH; Kim JH; Kim HA; Jung JY; Kim J; Choi IA; Lee KE
    Immunol Res; 2023 Oct; 71(5):709-716. PubMed ID: 37119459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
    Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
    J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.
    Murata K; Furu M; Yoshitomi H; Ishikawa M; Shibuya H; Hashimoto M; Imura Y; Fujii T; Ito H; Mimori T; Matsuda S
    PLoS One; 2013; 8(7):e69118. PubMed ID: 23874885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.
    Castro-Villegas C; Pérez-Sánchez C; Escudero A; Filipescu I; Verdu M; Ruiz-Limón P; Aguirre MA; Jiménez-Gomez Y; Font P; Rodriguez-Ariza A; Peinado JR; Collantes-Estévez E; González-Conejero R; Martinez C; Barbarroja N; López-Pedrera C
    Arthritis Res Ther; 2015 Mar; 17(1):49. PubMed ID: 25860297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NEAT1 regulates the proliferation and production of the inflammatory cytokines in rheumatoid arthritis fibroblast-like synoviocytes by targeting miR-204-5p.
    Xiao J; Wang R; Zhou W; Cai X; Ye Z
    Hum Cell; 2021 Mar; 34(2):372-382. PubMed ID: 33394349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated microRNA expression in rheumatoid arthritis families-a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls.
    Renman E; Brink M; Ärlestig L; Rantapää-Dahlqvist S; Lejon K
    Clin Rheumatol; 2021 Jun; 40(6):2387-2394. PubMed ID: 33210166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: A prospective cohort study.
    Liu Y; Han Y; Qu H; Fang J; Ye M; Yin W
    J Clin Lab Anal; 2019 Sep; 33(7):e22953. PubMed ID: 31245894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MALAT1-H19/miR-19b-3p axis can be a fingerprint for diabetic neuropathy.
    Rajabinejad M; Asadi G; Ranjbar S; Varmaziar FR; Karimi M; Salari F; Karaji AG; Rezaiemanesh A; Hezarkhani LA
    Immunol Lett; 2022 May; 245():69-78. PubMed ID: 35398394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients.
    Cheng P; Wang J
    J Clin Lab Anal; 2020 Aug; 34(8):e23329. PubMed ID: 32281166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-125a-3p inhibits cell proliferation and inflammation responses in fibroblast-like synovial cells in rheumatoid arthritis by mediating the Wnt/β-catenin and NF-κB pathways via targeting MAST3.
    Wang Y; Yin Z; Zhang N; Song H; Zhang Q; Hao X; Wang Z
    J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):560-567. PubMed ID: 34854396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis.
    Singh A; Patro PS; Aggarwal A
    Clin Rheumatol; 2019 Mar; 38(3):877-884. PubMed ID: 30511295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Gentisic Acid on Rheumatoid Arthritis Based on miR-19b-3p/RAF1 Axis.
    Ding D; Zhang Q; Zeng FJ; Cai MX; Gan Y; Dong XJ
    Chin J Integr Med; 2023 Jun; 29(6):508-516. PubMed ID: 36251141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.
    Tiedt S; Prestel M; Malik R; Schieferdecker N; Duering M; Kautzky V; Stoycheva I; Böck J; Northoff BH; Klein M; Dorn F; Krohn K; Teupser D; Liesz A; Plesnila N; Holdt LM; Dichgans M
    Circ Res; 2017 Sep; 121(8):970-980. PubMed ID: 28724745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
    Cheng Q; Chen X; Wu H; Du Y
    J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miRNAs improve the prediction of coronary atherosclerosis in patients with rheumatoid arthritis.
    Ormseth MJ; Solus JF; Sheng Q; Chen SC; Ye F; Wu Q; Oeser AM; Allen R; Raggi P; Vickers KC; Stein CM
    Clin Rheumatol; 2021 Jun; 40(6):2211-2219. PubMed ID: 33389220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.